MDxHealth is trading at $0.53, down 11.7% in pre-market, with the immediate catalyst unclear.

  • Shares fell from the September 21 close of $0.60.
  • Searches found no clear company-specific announcement, earnings update, regulatory action, or analyst catalyst; recent coverage likewise reported no fresh corporate announcement.
  • The broader pre-market market tone is only modestly softer.